Fulgent Genetics Inc. (FLGT)
16.71
-0.64 (-3.69%)
At close: Feb 20, 2025, 3:59 PM
16.75
0.24%
After-hours: Feb 20, 2025, 04:37 PM EST
undefined% (undefined)
| Bid | 16.3 |
| Market Cap | 511.11M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -5.52 |
| PE Ratio (ttm) | -3.03 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 16.97 |
| Volume | 148,965 |
| Avg. Volume (20D) | 256,933 |
| Open | 17.30 |
| Previous Close | 17.35 |
| Day's Range | 16.71 - 17.33 |
| 52-Week Range | 15.99 - 25.50 |
| Beta | undefined |
About FLGT
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children i...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Sep 29, 2016
Employees 1,184
Stock Exchange NASDAQ
Ticker Symbol FLGT
Website https://www.fulgentgenetics.com
Analyst Forecast
According to 1 analyst ratings, the average rating for FLGT stock is "Hold." The 12-month stock price forecast is $22, which is an increase of 31.66% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
Fulgent Genetics Inc. is scheduled to release its earnings on Feb 28, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
